AN INCREDIBLE EVENING OF WINE UNDER THE STARS WITH MASTER SOMMELIER ALPANA SINGH
WILL ANNOUNCE PLANS FOR INAUGURAL ARIZONA GALA IN 2018
SCOTTSDALE, Ariz. (April 12, 2017) – Richard J Stephenson, Cancer Treatment Centers of America (CTCA) and Gateway for Cancer Research (Gateway) Founder and Chairman and Dr. Stacie J. Stephenson, CTCA Chairman Functional Medicine and Gateway Board of Directors, will proudly host “Vino con Stelle” The exclusive and intimate evening of food, wine and entertainment under the stars will be held on Saturday, May 20, 2017 at the luxurious Silverleaf Club, 18701 North Silverleaf Drive, Scottsdale. The Stephensons will announce plans for Gateway’s inaugural 2018 gala at the lavish affair, which will benefit Gateway for Cancer Research, a non-profit dedicated to funding transformational cancer research.
The evening, led by lifestyle personality and former Good Morning Arizona host
Tara Hitchcock, will commence at 6:30 p.m. with cocktails served along Silverleaf’s stunning Mediterranean cobblestone entrance. As the sun sets at 7:30 p.m., surrounded by the majestic backdrop of the McDowell Mountains, guests will be escorted to an innovative gourmet five-course dinner prepared by Silverleaf’s acclaimed Executive Chef Michael Patton. The culinary journey will be enhanced with hand-selected wine pairings prepared and shared by celebrated Master Sommelier Alpana Singh, also known as a leading restauranteur, author and former host of Chicago’s Emmy-award winning television show Check, Please!
Following dinner, the Stephensons will present their guests with world renowned surprise entertainment, produced by Michael Ravenhill.
Tickets for “Vino con Stelle” are $750 per person, and all proceeds will benefit Gateway for Cancer Research. Limited sponsorships are available. For more information on purchasing tickets and other Gateway events, please contact Katie Wheat at 602.618.1595.or Katie.Wheat@GatewayCR.org, or visit the website at www.GatewayCR.org.
Current Gateway-funded clinical trials
Clinical trials funded at leading institutions worldwide
Funds one patient for one day at a Gateway-funded clinical trial